The MLL (HRX/ALL-1 gene is frequently disrupted in infantile leukemias and therapy-related leukemias and fused to various translocation partner genes. We previously showed that chimeric MLL proteins localize in the nuclei in a fashion similar to that of MLL protein even if the partner gene encodes a cytoplasmic protein and indicated the importance of the N-terminal portion of MLL common to various MLL translocations. This time we established an inducible expression system for chimeric MLL-LTG9 and truncated N-terminal MLL proteins (MLL-Zf (7)) in 32Dcl3 cells. By utilizing this system, we were able to show inhibition of Hox a7, Hox b7 and Hox c9 genes' expression by induced MLL-LTG9 and MLL-Zf(7). Up-regulation of Hox a7, Hox b7 and Hox c9 was observed when 32Dcl3 cells were cultured with granulocyte colony stimulating factor (G-CSF) in place of interleukin 3 and induction of MLL-LTG9 and MLL-Zf(7) was shown to suppress this upregulation. At the same time, expression of two mammalian Polycomb group genes, M33 and mel-18, which both reportedly aect Hox genes' expression, was not inhibited by MLL-LTG9 and MLL-Zf(7) induction. These results indicate that MLL has an important eect on the expression of at least some Hox genes in hematopoietic cells and suggest that inhibition of the proper expression of Hox genes by chimeric MLL proteins may dysregulate hematopoietic cell dierentiation and proliferation, which then can lead to leukemogenesis.
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Results and discussion
The mixed lineage leukemia (MLL) gene at 11q23, a human homolog of Drosophila trithorax gene (Gu et al., 1992; Tkachuk et al., 1992; Yamamoto et al., 1993a,b) , is involved in infantile leukemias (Abe and Sandberg, 1984; Kaneko et al., 1986; Pui et al., 1991) and therapy-related leukemias (Pui et al., 1989) through chromosomal translocations or partial tandem duplications (Schichman et al., 1994) . Since leukemic cells with MLL translocations often express biphenotypic markers, the translocations may occur at the level of a multipotent hematopoietic stem cell and aect normal dierentiation cell programs. Although more than twelve dierent fusion partner genes have been identi®ed, no shared structure has been recognized among the partner gene products (Trent et al., 1989; Waring and Cleary, 1997) . We previously demonstrated by means of Western blot analyses using MLL N-terminal speci®c antibody as well as partner gene product speci®c antibodies that chimeric MLL proteins could be detected in leukemia cell lines such as RS4;11, KOCL-45, CTS, KOPB-26, IMS-M1, KOCL-33 and KOCL-44 (Joh et al., 1996 (Joh et al., , 1997 . We constructed expression vectors and proved that MLL-LTG9, MLL-LTG19 and MLL-AF6 localize in the nuclei in a fashion similar to that of MLL protein, and that MLL-Zf(7), the N-terminal portion common to various chimeric MLL products, also localizes in the nuclei, suggesting the importance of the N-terminal portion of MLL (Joh et al., 1996 (Joh et al., , 1997 . We also showed that the MLL-Zf(7) protein can block G-CSF-induced dierentiation in 32Dcl3 cells, although 32Dcl3 cells expressed full length MLL in a stable manner demonstrated G-CSF-induced terminal differentiation into neutrophils (Joh et al., 1996) . These results indicate that chimeric MLL proteins may exert a dominant negative eect on the normal functions of MLL although the eects possibly exerted by the partner gene region cannot be disregarded. MLL-AF9/ LTG9 and HRX ± ENL (MLL-LTG19) were demonstrated to induce myeloid leukemias in mice by means of, respectively, a knock-in model and a retroviral gene transfer model (Corral et al., 1996; Lavau et al., 1997) . In Drosophila and mice, both trithorax and MLL are involved in the maintenance, but not initiation, of Hox genes' expression during embryonic development (Kennison, 1995; Yu et al., 1995) . Since the controlled expression of Hox genes is indispensable for hematopoietic cell dierentiation (Sauvageau et al., 1994) , leukemogenesis by MLL translocation may be caused by alterations in the expression of Hox genes. 32Dcl3 cells, which are murine IL-3 dependent myeloid progenitor cells, can be maintained in RPMI 1640 medium containing 5% FCS with IL-3, and show terminal dierentiation into neutrophils when cultured with G-CSF in place of IL-3 (Mavilio et al., 1989) . We reported that transfectants expressing MLL-Zf(7) in a stable manner could be generated, but no transfectant with stable expression of MLL-LTG9 and MLL-LTG19 proteins could be obtained in spite of several trials (Joh et al., 1996) . Therefore, we generated an inducible expression system in 32Dcl3 cells by utilizing the LacSwitch II Inducible Mammalian Expression System (Stratagene, La Jolla, CA, USA) in order to examine genes expressed dierentially in the induction of MLL-LTG9 and MLL-Zf(7). This system is composed of a eukaryotic lac-repressor-expressing vector, pCMVLacI, and a eukaryotic lac-operatorcontaining vector, pOPRSVI/MCS. cDNAs encoding MLL-LTG9 (5.1 kb) derived from pCXN2-MLL-LTG9 (Joh et al., 1996) and MLL-Zf(7) (3.75 kb) derived from pCXN2-MLL-Zf(7) (Joh et al., 1996) were cloned into the XhoI and XbaI sites of the ) and two zinc ®nger regions ( ) are shown, as are the regions homologous to DNA methyltransferase ( ) and to Drosophila trithorax ( ) in the 3969 aa MLL polypeptide (Yamamoto et al., 1993b; Ma et al., 1993) . MLL-LTG9 has a fusion site at aa number 1444 of MLL with aa number 376 of LTG9 ( ) giving rise to a 1637 aa polypeptide (Iida et al., 1993; Nakamura et al., 1993) . Numbers (above and below the products) represent amino acid positions. (b) Flow cytometric analysis of 32DLacGFP and 32DLacML9 cells. Transfectants were cultured in the presence (+) or the absence (7) of 5 mM IPTG for 24 h and washed twice in phosphate buered saline, and then subjected to¯ow cytometry using a FACScan (Becton-Dickinson, Mountain View, CA, USA). The X-axis shows FL1 signal intensity for the detection of the¯uorescence derived from GFP and the Y-axis shows cell counts. (c,d) Western blot analysis with anti-LTG9 and anti-N-MLL antibodies. 32DLacML9, 32DLacZf(7), 32DLacGFP and 32Dcl3 cells expressing fulllength MLL protein in a stable manner as well as 32Dcl3 cells transfected with the pCXN2 vector, which is an expression vector for full-length MLL (Joh et al., 1996) , were shown. Transfectants were cultured in the presence (+) or the absence (7) or 5 mM IPTG for 24 h and lysed by using a 16SDS ± PAGE sample buer (62.5 mM Tris, pH 6.8, 2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.01% bromophenol blue) at a density of 1610 6 cells/100 ml and boiled for 5 min. Ten ml aliquots of these lysates were examined on 6% SDS-polyacrylamide gels as described previously (Joh et al., 1996) . An ECL detection kit (Amersham-Japan, Tokyo, Japan) was used for visualization. Speci®c bands of MLL-LTG9 detected by anti-LTG9 and anti-N-MLL antibodies are indicated by arrowheads (lanes 4 and 5) (c) Speci®c bands of MLL-Zf(7) and full-length MLL detected by anti-N-MLL antibody are indicated by arrowheads (lanes 4 and 6) (d) Size markers are shown on the panels (kDa) pOPRSVI/MCS vector to generate pOPRSVI-MLL-LTG9 and pOPRSVI-MLL-Zf(7), respectively ( Figure  1a ). cDNA encoding green¯uorescent protein (GFP, 0.76 kb) derived from pRK7GFP (kindly provided by Dr Tsien, University of California, San Diego, USA) was cloned into the XbaI and NotI sites of pOPRSVI/ MCS to generate pOPRSVI-GFP (Figure 1a ). For stable transfectants in 32Dcl3 cells, electroporation was performed with 10 mg of linearized pOPRSVI-MLL-LTG9 or pOPRSVI-MLL-Zf(7) or pOPRSVI-GFP, together with 10 mg of linearized pCMVLacI, by utilizing a Gene Pulser (BioRad-Japan, Tokyo, Japan) at 960 mF, 450 V. After selection in medium containing 1 mg/ml of Geneticin (Sigma, St Louis, MO, USA) and 100 mg/ml of Hygromycin B (Sigma), clones were isolated by limiting dilution and screened for MLL-LTG9, MLL-Zf (7) and GFP expression. Clones were induced by culturing in 5 mM isopropyl-b-D-thiogalactopyranoside (IPTG) for 24 h and examined for MLL-LTG9 and MLL-Zf (7) by Western blot analysis, and for GFP by¯ow cytometric analysis utilizing a FACScan (Becton-Dickinson, Mountain View, CA, USA). Nine out of 10 clones for MLL-LTG9, 10 out of 10 clones for MLL-Zf(7) and 34 out of 34 clones for GFP were identi®ed as inducible (data not shown). Three inducible clones from each construct, labeled 32DLacML9, 32DLacZf(7) and 32DLacGFP, were mixed again and subjected to the experiments as bulk clones. Flow cytometric analysis showed inducible expression of GFP in 32DLacGFP cells, but not in 32DLacML9 cells, in response to IPTG (Figure 1b) . Induction of MLL-LTG9 and MLL-Zf(7) proteins was examined by Western blot analysis (Figure 1c and d) . Induced MLL-LTG9 was detected as a speci®c 185 kDa band (lanes 4 and 5) by both anti-LTG9 and anti-N-MLL antibodies (Joh et al., 1996) in 32DLacML9 cells, but not in 32DLacGFP cells (Figure 1c) . The 185 kDa band of MLL-LTG9 was detectable in 32DLacML9 cells without IPTG by both anti-N-MLL and anti-LTG9 antibodies after long exposure (data not shown). Furthermore, extra bands, probably degraded or prematurely terminated products of MLL-LTG9, were detected approximately from 155 kDa to 110 kDa in lanes 3 and 4 (Figure 1c) . These results may indicate that there is low basal expression of MLL-LTG9 in the repressed state, however, these extra bands are not clearly detected by N-terminal MLL speci®c antibody (Figure 1c , lanes 5 and 6). Induced MLL-Zf(7) was detected as a speci®c 155 kDa band (lane 4) by anti-N-MLL antibody in 32DLacZf(7) cells, but not in 32DLacGFP cells (Figure 1d ). Similar to the case of MLL-LTG9, the 155 kDa band of MLL-Zf(7) was also detectable in 32DLacZf(7) cells without IPTG after long exposure (data not shown), indicating the presence of low basal expression of MLL-Zf(7) in a repressed state. Densitometric analysis revealed that induced MLL-LTG9 were expressed at more than 100 6 cells/100 ml and boiled for 5 min. Ten ml aliquots of these lysates were examined on 6% polyacrylamide gels at the indicated time points. An ECL detection kit (Amersham-Japan) was used for visualization and MLL-Zf(7) proteins at more than 50 times higher levels compared to the repressed state (data not shown). Figure 2 shows the time course of GFP, MLL-LTG9 and MLL-Zf(7) induction. The induced GFP became detectable 3 h after the addition of IPTG (Figure 2a) , and the induced MLL-LTG9 and MLLZf(7) proteins after 6 h ( Figure 2b ). This induction system enabled us to establish chimeric MLL-LTG9 expressing cells which had been dicult with the previously used construct (Joh et al., 1996) . This system should be applicable for various experiments to analyse the functions of MLL or chimeric MLL proteins for clari®cation of their roles in leukemogenesis. In this study, we examined Hox genes' expression by utilizing this system because Hox a7 and Hox c9 genes' expression are reportedly regulated by MLL (Yu et al., 1995) .
It has been reported that the Hox genes of Hox-A, Hox-B and Hox-C clusters are expressed in hematopoetic cells, but not the Hox genes of Hox-D cluster (Lawrence and Largman, 1992). Therefore, Hox-A (a1, a2, a3, a4, a5, a7, a9, a10, a11 and a13), Hox-B (b2, b3, b4, b5, b6 and b7) and Hox-C (c4, c5, c6, c8, c9 and c10) genes were examined in order to determine whether they were expressed in 32Dcl3 cells. Although Northern blot analysis did not demonstrate any Hox gene expression, reverse transcriptase-medaited polymerase chain reaction (RT ± PCR) followed by ethidium bromide-containing-agarose gel electrophoresis could identify Hox a7, Hox b7 and Hox c9 gene expression (data not shown). The expression of Hox a7, Hox b7 and Hox c9 genes was examined in 32DLacML9, 32DLacZf(7) and 32DLacGFP cells with or without IPTG (Figure 3) . In 32DLacGFP cells, no changes in any of the three Hox genes' expression was recognized regardless of the presence or absence of IPTG. In 32DLacML9 cells, Hox a7, Hox b7 and Hox c9 genes were all expressed when cultured without IPTG, but they were all suppressed when the chimeric MLL-LTG9 protein was induced with IPTG. Interestingly, the induced MLL-Zf(7) protein, the Nterminal portion of MLL, was also found to suppress expression of these Hox genes in 32DLacZf(7) cells. We previously showed that MLL-Zf(7) protein conferred a growth advantage to 32Dcl3 cells whereas the full-length MLL protein did not (Joh et al., 1996) . Therefore, 32Dcl3 cells expressing the full-length MLL protein in a stable manner (Figure 1d) (Joh et al., 1996) were examined and found to express Hox a7, Hox b7 and Hox c9 genes (Figure 3) . It is reported that Hox genes in the 3' end of the cluster tend to be expressed in hematopoietic progenitors, while more 5' genes are expressed in more dierentiated cells (Sauvageau et al., 1994) . On the basis of these ®ndings, it is thought that inhibition of the proper expression of Hox genes by chimeric MLL proteins may be related to leukemogenesis as a result of blocking hematopoietic cell dierentiation. Furthermore, analysis of knockout mice demonstrated that MLL is required for segment identity by showing the spatially altered expression of Hox a7 and Hox c9 genes (Yu et al., 1995) . Thus, it is noteworthy that in the present study MLL was found to positively regulate the same Hox genes, Hox a7 and Hox c9, in hematopoietic cells. Corral et al. (1996) and Lavau et al. (1997) discussed their results with a gainof-function model utilizing a knock-in model and a retroviral gene transfer model. In the knock-in model system, none of the ES cells with the truncated Nterminal MLL contributed to any blood cells. Furthermore, partial tandem duplications of MLL Nterminal portions were reported in a subset of myeloid leukemias (Schichman et al., 1994) . These ®ndings suggest an important role of MLL N-terminal portion common to various translocations for leukemogenesis Figure 3 RT ± PCR analysis of Hox a7, Hox b7, Hox c9, M33 and mel-18 expression. 32Dcl3 cells expressing full-length MLL in a stable manner (Joh et al., 1996) were cultured in the absence of IPTG. 32DLacML9, 32DLacGFP and 32DLacZf(7) cells were cultured in the presence (+) or the absence (7) of 5 mM IPTG for 24 h. Total RNA was isolated using Isogen (Nippon gene, Tokyo, Japan) according to the manufacturer's instructions. RT ± PCR for a total volume of 50 ml was performed by using an RT ± PCR kit (Stratagene, La Jolla, CA, USA) according to the manufacturer's instructions. The reaction time consisted of 40 cycles of denaturation at 948C for 1 min, annealing at 608C for 1 min, and extension at 728C for 1 min. At the end of each round of 40 cycles, further extension was performed for 10 min at 728C. Ten ml aliquots of each PCR ampli®cation reaction was electrophoresed in 2% agarose gel (1% Agarose S (Nippon gene) and 1% Nusieve agarose (FMC BioProducts, Rockland, ME, USA)) and transferred onto Hybond N + membranes (Amersham). The membranes were hybridized with each of the g-32 P ATP-end-labeled probes (internal oligomers) at 428C overnight, washed for 30 min at room temperature and for 30 min at 428C in 26SSC and 0.1% SDS solution, and visualized by autoradiography. Testes of B6 mice were used as positive controls and distilled water (DW) instead of cDNA samples was used as a negative control. The following primers and probes were used: (1) Hox a7: 5' primer 5'-GAACTGGAGAAGGAATTCCAas well as for hematopoietic cell proliferation and dierentiation. This role does not con¯ict, however, with the suppressive eect of induced MLL-Zf(7) on Hox gene expression described in this paper. Although the present data on Hox gene regulation may not be directly relevant to leukemogenesis because 32Dcl3 cells are already immortal, it is important to note that the altered MLL gene products aected Hox genes. This suggests the possibility that other Hox genes expressed in dierent stages of dierentiation may also be aected.
Recently, ARP1, which contains a short motif shared with several Hox genes, was cloned as a target gene for MLL (Arakawa et al., 1998) . We examined ARP1 expression in mouse tissue with the RT ± PCR method and found that ARP1 is expressed in testis and bone marrow, but not in 32Dcl3 cells (data not shown), suggesting that MLL may regulate dierent target genes in 32Dcl3 cells. In Drosophila, the maintenance of the homeotic gene expression during embryogenesis is dependent on the trithorax and Polycomb group gene products (Simon et al., 1992) . Recent studies have revealed that the M33 gene, a mammalian homolog of the Drosophila Polycomb gene, and the mel-18 gene, a mammalian homolog of the Drosophila Posterior sex comb gene, aect Hox gene expression (Core et al., 1997; Akasaka et al., 1996) . We therefore examined the expression patterns of M33 and mel-18 genes in our newly established inducible expression system (Figure 3) . We found that both M33 and mel-18 genes were expressed in all 32DLacGFP, 32DLacML9 and 32DLacZf(7) cells regardless of the presence or absence of IPTG ( Figure  3 ), suggesting that chimeric MLL proteins may suppress the expression of Hox genes independent of that of mammalian Polycomb genes.
The eect of G-CSF stimulation was examined in the medium containing G-CSF without IL-3 (Figure 4) . In 32Dcl3 cells expressing the full-length MLL protein in a stable manner, Hox a7, Hox b7 and Hox c9 genes were all up-regulated by G-CSF stimulation. Similarly, in 32DLacGFP cells, G-CSF stimulation showed upregulation of Hox a7, Hox b7 and Hox c9 genes regardless of the presence or absence of IPTG. In 32DLacML9 and 32DLacZf(7) cells, however, G-CSF-induced up-regulation of these three Hox genes was inhibited in the presence of IPTG although upregulation was observed in its absence. These results indicate that MLL may be involved in not only maintenance, but also G-CSF-induced up-regulation of Hox genes' expression in hematopoietic cells.
In summary, we established a system to induce expression of chimeric MLL-LTG9 and truncated Nterminal MLL proteins in 32Dcl3 cells. By utilizing this system, it was clari®ed that MLL regulates the expression of Hox genes in hematopoietic cells. This system can be expected to become a powerful tool for the analysis of the functions of MLL or chimeric MLL proteins. (7) proteins. 32Dcl3 cells expressing full-length MLL, 32DLacML9, 32DLacZf(7) and 32DLacGFP cells were cultured in the presence (+) or the absence (7) of 5 mM IPTG and/or G-CSF for 24 h and total RNA was isolated by using Isogen (Nippon gene) according to the manufacturer's instructions. RT ± PCR was performed with an RT ± PCR kit (Stratagene) in a total volume of 50 mM according to the manufacturer's instructions. The ampli®cation procedure and primers used were the same as for the procedures described in Figure 3 . Ten ml aliquots of each of the PCR ampli®cation reactions was electrophoresed in 3% agarose gel (1% Agarose S (Nippon gene) and 2% Nusieve agarose (FMC BioProducts)) and visualized with ethidium bromide¯uorostaining. Testes of B6 mice were used as positive controls and DW instead of cDNA samples as negative controls
